移动健康(mHealth)干预对海湾国家成人2型糖尿病患者血糖结局的有效性:一项系统综述与荟萃分析。
完整摘要 · 中文译文
背景:2型糖尿病(T2DM)在海湾国家构成重大公共卫生挑战,其患病率位居全球最高之列;尽管移动健康(mHealth)干预已在全球范围内显示出对糖尿病自我管理的益处,但区域特异性证据仍然有限。 目的:评估mHealth干预与常规护理相比对海湾国家成人T2DM患者血糖控制的有效性。 方法:按照PRISMA指南开展系统综述和荟萃分析。检索PubMed、Scopus、Web of Science和Cochrane CENTRAL,检索时限为建库至2025年5月15日。纳入比较mHealth干预与常规护理在海湾国家成人T2DM患者中应用的随机对照试验(RCT)和分析性观察性研究。使用Cochrane RoB 2工具和Newcastle-Ottawa量表评估偏倚风险。采用随机效应荟萃分析估计HbA1c的合并均数差。 结果:检索共获得516条记录,其中三项涉及371名参与者(mHealth n = 216;常规护理 n = 155)的研究符合纳入标准。两项研究在沙特阿拉伯开展,一项在阿拉伯联合酋长国开展。干预措施包括基于WhatsApp的糖尿病自我管理教育、mHealth支持的健康指导以及带远程监测的混合护理模式。主要荟萃分析显示,与常规护理相比,mHealth干预在HbA1c降低方面具有统计学显著性,有利于mHealth干预(合并均数差 - 0.86%;95% CI:-1.48至-0.24;I² = 0%)。然而 r,仅纳入随机对照试验(RCT)的敏感性分析得出的估计值不确定,合并均数差为 -1.02%(95% CI:-6.34 至 4.29;I² = 49%)。 结论:有限证据提示,移动健康(mHealth)干预可能改善海湾国家成人2型糖尿病患者的血糖控制。然而,鉴于研究数量较少且敏感性分析结果不确定,对上述证据应谨慎解读。仍需更大规模、高质量、随访期更长的随机对照试验以确认其有效性并为政策提供依据。
完整摘要 · 英文原文
BACKGROUND: Type 2 diabetes mellitus (T2DM) poses a major public health challenge in Gulf countries and has among the highest global prevalence; although mobile health (mHealth) interventions have demonstrated global benefits for diabetes self-management, region-specific evidence remains limited. OBJECTIVE: To assess the effectiveness of mHealth interventions compared with usual care for glycemic control among adults with T2DM in Gulf countries. METHODS: A systematic review and meta-analysis were conducted following PRISMA guidelines. PubMed, Scopus, Web of Science, and Cochrane CENTRAL were searched from inception to May 15, 2025. Randomized controlled trials (RCTs) and analytical observational studies comparing mHealth interventions with usual care in adults with T2DM in Gulf countries were included. The risk of bias was assessed using the Cochrane RoB 2 tool and the Newcastle-Ottawa Scale. A random-effects meta-analysis estimated pooled mean differences in HbA1c. RESULTS: The search yielded 516 records, of which three studies involving 371 participants (mHealth n = 216; usual care n = 155) met the inclusion criteria. Two studies were conducted in Saudi Arabia, and one was conducted in the United Arab Emirates. Interventions included WhatsApp-based diabetes self-management education, mHealth-enabled health coaching, and hybrid care models with remote monitoring. The primary meta-analysis revealed a statistically significant reduction in HbA1c, favoring mHealth interventions compared with usual care (pooled mean difference - 0.86%; 95% CI: -1.48 to - 0.24; I² = 0%). However, sensitivity analysis including only RCTs yielded an inconclusive estimate, with a pooled mean difference of - 1.02% (95% CI: -6.34 to 4.29; I² = 49%). CONCLUSIONS: Limited evidence suggests that mHealth interventions may improve glycemic control among adults with type 2 diabetes in Gulf countries. However, the evidence should be interpreted cautiously given the small number of studies and the inconclusive findings of the sensitivity analysis. Larger, high quality RCTs with longer follow-up periods are needed to confirm their effectiveness and inform policy.